scispace - formally typeset
L

Lourdes Hernández

Researcher at University of Barcelona

Publications -  14
Citations -  2408

Lourdes Hernández is an academic researcher from University of Barcelona. The author has contributed to research in topics: Sleep apnea & Continuous positive airway pressure. The author has an hindex of 11, co-authored 14 publications receiving 2320 citations.

Papers
More filters
Journal Article

Treatment with Continuous Positive Airway Pressure Is Not Effective in Patients with Sleep Apnea but No Daytime Sleepiness

TL;DR: In patients with an apnea-hypopnea index of 30 or greater and no subjective daytime sleepiness, continuous positive airway pressure did not modify quality of life, objective sleepiness or vigilance as discussed by the authors.
Journal ArticleDOI

Treatment with Continuous Positive Airway Pressure Is Not Effective in Patients with Sleep Apnea but No Daytime Sleepiness: A Randomized, Controlled Trial

TL;DR: The available evidence supports the notion that CPAP is an effective symptomatic treatment for patients with the sleep apneahypopnea syndrome, and a multicenter randomized, placebo-controlled, parallel-group study was designed to evaluate the short-term effects of CPAP on quality of life, objective sleepiness, cognitive function, and arterial blood pressure in nonsleepy patients with a pathologic apnehypopna index.
Journal ArticleDOI

Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome.

TL;DR: The relief of sleepiness and other SAHS-related clinical symptoms and improvement in perceived health status was much greater in Group 2 receiving CT + CPAP compared with Group 1, only receiving CT.
Journal ArticleDOI

Alternative methods of titrating continuous positive airway pressure: a large multicenter study.

TL;DR: Autoadjusted titration at home and predicted formula titration with domiciliary adjustment can replace standard titration in sleep apnea patients, which could lead to considerable savings in cost and to significant reductions in the waiting list.